Resources

Accelerating Viral Vectors Commercialization to Market through Suspension Platform with Greater Predictability

Abstract: Developing innovative advanced therapies is one of our greatest opportunities to dramatically improve patients’ lives. In this webinar, we will discuss our recent technical advancement on efficient viral vector manufacturing process development. From cell line development, suspension culture of HEK293 cells, transfection, to cell culture optimization and purification process development, a series of progress …Read More >

Resource Type: Webinar
Resource Topic: Clinical & Commercial Manufacturing Process Development

VIEW

Accelerating Viral Vectors Commercialization through AAV Suspension Platform

  Summary of the Presentation given at Phacilitate in Miami (2020): – Established suspension HEK293 cell line – In-stock raw materials with established batch records – State-of-the-art GMP manufacturing facilities with enhanced scalability that range up to 1000L – Established and dedicated process & analytical development teams – Strong and dedicated technical guidance including regulatory …Read More >

Resource Type: Presentation
Resource Topic: Clinical & Commercial Manufacturing Process Development

VIEW

Phacilitate Poster 2 – Downstream Development Challenges and Progress for AAVs

From clarification to separation of empty and full capsids, each downstream processing step has its challenges in viral vector manufacturing at a CDMO.

Resource Type: Poster
Resource Topic: Process Development

VIEW

Phacilitate Poster 1 – Accelerating Development and Manufacturing Platform for Viral Vector

In this poster, we will discuss our recent technical advancement on efficient viral vector manufacturing process development.

Resource Type: Poster
Resource Topic: Process Development

VIEW

Case Study in Conducting Chemical Safety Assessments for Single- and Multi-Use Manufacturing Components

About this event Extractable and leachable studies of single- and multi-use manufacturing components should be followed up with a chemical safety assessment to understand the chemical risks based on the toxicity of the chemical, the dose and the exposure duration of the drug product, and the patient population for its intended use. This case study …Read More >

Resource Type: Webinar
Resource Topic: Laboratory Testing

VIEW